Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo

Slični predmeti

• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  od: Howell, I, i dr.
  Izdano: (2024)
• Mepolizumab and exacerbations of refractory eosinophilic asthma.
  od: Haldar, P, i dr.
  Izdano: (2009)
• Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
  od: Shrimanker, R, i dr.
  Izdano: (2017)
• Exacerbations of severe asthma in patients treated with mepolizumab
  od: Shrimanker, R, i dr.
  Izdano: (2018)
• Mepolizumab in refractory eosinophilic asthma.
  od: Pavord, I, i dr.
  Izdano: (2010)